ALPROZOLAM KINETICS IN THE ELDERLY - RELATION TO ANTIPYRINE DISPOSITION

被引：0

作者：

MOSCHITTO, LJ ^{[1
]}

GREENBLATT, DJ ^{[1
]}

DIVOLL, M ^{[1
]}

ABERNETHY, DR ^{[1
]}

SMITH, RB ^{[1
]}

SHADER, RI ^{[1
]}

机构：

[1] TUFTS UNIV,NEW ENGLAND MED CTR,BOSTON,MA 02111

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1981年 / 29卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：267 / 267

页数：1

共 50 条

[21] ANTIPYRINE, ERYTHROMYCIN AND OXYTETRACYCLINE DISPOSITION IN EXPERIMENTAL FASCIOLIASIS
BURROWS, GE
TASLER, J
BORAY, JC
EGERTON, J
RESEARCH IN VETERINARY SCIENCE, 1992, 53 (02) : 191 - 197
[22] EFFECTS OF UREA ON HEXOBARBITAL AND ANTIPYRINE DISPOSITION IN RATS
VALENTOVIC, M
BACHMANN, K
PHARMACOLOGY, 1980, 21 (03) : 167 - 174
[23] ANTIPYRINE KINETICS IN OBESITY
ABERNETHY, DR
GREENBLATT, DJ
ALLEN, MD
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (02) : 243 - 243
[24] DISPOSITION AND OXIDATIVE-METABOLISM OF ANTIPYRINE IN RAT
AARBAKKE, J
ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1978, 43 (01): : 64 - 68
[25] INFLUENCE OF PHENOBARBITAL ON DISPOSITION OF CLONAZEPAM AND ANTIPYRINE IN DOG
BEKERSKY, I
MAGGIO, AC
MATTALIANO, V
BOXENBAUM, HG
MAYNARD, DE
COHN, PD
KAPLAN, SA
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1977, 5 (05): : 507 - 512
[26] THE EFFECT OF ZILEUTON ON ANTIPYRINE AND INDOCYANINE GREEN DISPOSITION
STPETER, JV
BRAECKMAN, RA
GRANNEMAN, GR
LOCKE, CS
CAVANAUGH, JH
AWNI, WM
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (03) : 299 - 308
[27] EFFECT OF THE IMMUNOMODULATOR TILORONE ON ANTIPYRINE DISPOSITION IN THE RAT
SVENSSON, CK
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (10) : 946 - 948
[28] DISPOSITION OF METHOTREXATE INULIN ANTIPYRINE AND CORTISOL IN ELASMOBRANCHII
WALKER, MD
ADAMSON, RH
OLIVERIO, VT
HAHN, MA
RALL, DP
PHARMACOLOGIST, 1967, 9 (02): : 241 - &
[29] DISPOSITION OF ANTIPYRINE IN AFRICAN PATIENTS WITH HODGKINS LYMPHOMA
JUMA, FD
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 24 (06) : 809 - 811
[30] ANTIPYRINE DISPOSITION IN MILK AND SALIVA OF LACTATING WOMEN
BERLIN, CM
VESELL, ES
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (01) : 38 - 44

← 1 2 3 4 5 →